Telehealth Revolution: Hims & Hers Navigates Weight-Loss Drug Market Amid Employer Cutbacks Hims & Hers Health could see a growth surge as employers drop coverage for weight-loss drugs due to soaring costs.…
Hims & Hers shares dip amid rising selling pressure Hims & Hers Health slips 2.35% today to $31.93 as technical selling emerges; momentum mixed near key averages and support.…
Hims & Hers Stock Tumbles As Regulatory Jitters Spike Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
$30.79 support helps Hims & Hers Health stock trade flat despite recent pullback Hims & Hers Health trades at $32.7 today, slipping 0.79%. Check key support and resistance levels in the latest technical…
Barclays Raises Price Target On Hims & Hers Health (NYSE: HIMS) As Weight Loss Business Drives Momentum Barclays has maintained its Overweight rating on Hims & Hers Health, Inc. (NYSE: HIMS) while raising its price target to…
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase? We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Hims & Hers…
Hims & Hers Health (HIMS) Expands GLP 1 Reach, Is The Upside Already Priced In? Hims & Hers Health (HIMS) is back in focus as investors weigh its expanding GLP-1 weight-loss offering, its new partnership…